137 related articles for article (PubMed ID: 7513202)
1. Role of cyclic nucleotides in rapid platelet adhesion to collagen.
Polanowska-Grabowska R; Gear AR
Blood; 1994 May; 83(9):2508-15. PubMed ID: 7513202
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
4. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
5. YC-1, a novel activator of platelet guanylate cyclase.
Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
[TBL] [Abstract][Full Text] [Related]
6. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
[TBL] [Abstract][Full Text] [Related]
7. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
[TBL] [Abstract][Full Text] [Related]
8. Developmental Differences in Platelet Inhibition Response to Prostaglandin E1.
Palma-Barqueros V; Torregrosa JM; Caparrós-Pérez E; Mota-Pérez N; Bohdan N; Llanos MDC; Begonja AJ; Sola-Visner M; Vicente V; Teruel-Montoya R; Rivera J; Ferrer-Marín F
Neonatology; 2020; 117(1):15-23. PubMed ID: 31786577
[TBL] [Abstract][Full Text] [Related]
9. Triggering of beta 1-integrin chain induces platelet adhesion to cultured endothelium.
Del Maschio A; Martín-Padura I; Bernasconi S; Dejana E
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2663-71. PubMed ID: 9409240
[TBL] [Abstract][Full Text] [Related]
10. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
[TBL] [Abstract][Full Text] [Related]
11. Are cyclic nucleotides involved in the initiation of mitogenic activation of human lymphocytes?
Kaever V; Resch K
Biochim Biophys Acta; 1985 Aug; 846(2):216-25. PubMed ID: 2411297
[TBL] [Abstract][Full Text] [Related]
12. Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Nezu A; Shinoda H; Minami M
Br J Pharmacol; 1996 Jan; 117(2):299-304. PubMed ID: 8789382
[TBL] [Abstract][Full Text] [Related]
13. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitrovasodilators on platelet cyclic nucleotide levels in rabbit blood; role for cyclic AMP in synergistic inhibition of platelet function by SIN-1 and prostaglandin E1.
Bowen R; Haslam RJ
J Cardiovasc Pharmacol; 1991 Mar; 17(3):424-33. PubMed ID: 1711604
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets.
Rosado JA; Porras T; Conde M; Sage SO
J Biol Chem; 2001 May; 276(19):15666-75. PubMed ID: 11278478
[TBL] [Abstract][Full Text] [Related]
16. Human monocyte killing of Staphylococcus aureus: modulation by agonists of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate.
O'Dorisio MS; Vandenbark GR; LoBuglio AF
Infect Immun; 1979 Nov; 26(2):604-10. PubMed ID: 44704
[TBL] [Abstract][Full Text] [Related]
17. Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside.
Jang EK; Azzam JE; Dickinson NT; Davidson MM; Haslam RJ
Br J Haematol; 2002 Jun; 117(3):664-75. PubMed ID: 12028040
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
19. On the interrelationship of prostaglandin endoperoxide G2 and cyclic nucleotides in platelet function.
Claesson HE; Malmsten C
Eur J Biochem; 1977 Jun; 76(1):277-84. PubMed ID: 195812
[TBL] [Abstract][Full Text] [Related]
20. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
Ferreira MA; do Nascimento NR; de Sousa CM; Pessoa OD; de Lemos TL; Ventura JS; Schattner M; Chudzinski-Tavassi AM
Br J Pharmacol; 2008 Jul; 154(6):1216-24. PubMed ID: 18516074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
